Algo version: 0.98b
Panacea Biotec Limited is listed at the NSE Exchange
Panacea Biotec Limited [PANACEABIO.NS]
NSE Sector: Healthcare Industry:Biotechnology

Is Panacea Biotec Limited stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, Panacea Biotec Limited pays dividends. Last time was Monday 10th of October 2011 where the investors holding the stock on Monday 19th of September 2011 were paid INR0.75 per share. Over the last 9 times between 2002 and 2011, Panacea Biotec Limited has paid INR17.5 with an average of INR1.94 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Panacea Biotec Limited 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was INR136.00, you would have made a profit of INR109.92 per share or 80.82%

Yes, the average daily trading liquidity for Panacea Biotec Limited is INR595 928 thousand. You should therefore be able to get in and out of your positions relatively fast.

Panacea Biotec Limited has no real debt, which is good in periods of high inflation. With a high cash flow to debt ratio of 3.56, the company's ability to pay off the debt is good. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.

We have calculated the inflation risk for Panacea Biotec Limited to be low [0.3 of 1]

US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.